There are countless medical conditions without effective therapeutic options. By using machine learning and artificial intelligence to understand the relationships between amino acid sequence, molecular structure, and protein function, researchers can unearth new therapeutic options to address unmet clinical needs. In this webinar brought to you by Thermo Fisher Scientific, Alex Snyder from Generate:Biomedicines will explore how rapidly advancing machine learning technology identifies novel therapeutic targets, optimizes drug design, and speeds up drug development.
Topics to be covered
- Filling critical gaps in medical treatment using AI technologies
- Synergistically integrating dry- and wet-lab approaches to accelerate drug development
Wednesday, April 3rd, 2024 | 9:00 AM - 10:00 AM Eastern Time
This webinar will be available to view live and on demand.
Speaker

Alex Snyder, MD
Executive Vice President, Research and Development
Generate:Biomedicines